1)长期资金入市，权益投资有望贡献弹性。2)行业投资组合结构：债券和权益投资比例有望持续提升， 债券占比维持高位同时结构不断优化，边际来看占比增速或将放缓。长期资金入市，股票配置占比预计 将持续提升。人身险公司纯股票配置占比8.4%，同比+0.9 pct，连续三个季度保持回升;财险公司纯股票 占比7.6%，同比+0.4 pct，同样延续小幅上行趋势。3)IFRS9下的投资组合：OCI有望持续增配，以高股 息高分红标的寻找确定性。 内含价值：NBV有望持续改善，头部险企EV增长分化，聚焦资负匹配能力 伴随分红险切换和渠道"报行合一"费用管控，长期投资收益率假设调整的负面影响有望逐步消化，潜在 利差损压力有望逐步减轻，后续资产负债更为匹配、业务结构和渠道质态较好的险企有望更为受益， ROEV整体表现有望显著回暖。 风险提示：政策不及预期、资本市场波动加大、居民财富增长不及预期、长期利率下行超预期、险企改 革不及预期。 1)保费增长：新单保费预计继续承压，结构质态有望改善，NBV预计延续正增长。新单保费方面，该行 预计2025年主要上市险企整体仍将承压，除新华保险外，预计将维持负增长，总保费方面，由于有过去 续期保 ...

The Unrecognized Faces of Critical Illness CytoSorbents Corporation Q3 2023 Earnings Conference Call November 9, 2023 Conference Call Participants Moderator: Taylor Devlin CytoSorbents Corporation Phillip Chan, MD, PhD Chief Executive Officer Vincent Capponi, MS President and Chief Operating Officer Efthymios "Makis" Deliargyris MD, FACC, FESC, FSCAI Chief Medical Officer 2 Kathleen Bloch, MBA, CPA Chief Financial Officer Christian Steiner, MD Executive VP Sales & Marketing Managing Director CytoSorbents Eu ...

The Unrecognized Faces of Critical Illness CytoSorbents Corporation Q4 2023 and FY 2023 Earnings Conference Call March 14, 2024 Conference Call Participants Moderator: Taylor Devlin CytoSorbents Corporation Phillip Chan, MD, PhD Chief Executive Officer Vincent Capponi, MS President and Chief Operating Officer Efthymios "Makis" Deliargyris MD, FACC, FESC, FSCAI Chief Medical Officer Kathleen Bloch, MBA, CPA Chief Financial Officer Christian Steiner, MD Executive VP Sales & Marketing Managing Director CytoSor ...

Core Points - FirstFarms' Board of Directors has decided to issue 42,000 warrants, allowing the subscription of shares totaling 420,000 DKK [1] - The exercise price for the warrants is set at 65.16 DKK per share, with allocations made cost-free to Co-CEOs and other managers [2] - The total market value of the issued warrants is estimated at 546,040 DKK, calculated using the Black-Scholes model [4] Summary by Sections Warrants Allocation - The Board has allocated 25,000 warrants to the two Co-CEOs and 17,000 warrants to other managers [2] - The warrants can be utilized within a 4-week period following the release of the annual report for the year 2027 [2] Conditions of Utilization - If an employee resigns as a "bad leaver," unutilized warrants will lapse immediately without compensation [3] - Employees resigning as "good leavers" will retain their rights to the allotted warrants [3] Financial Valuation - The market value of the warrants is based on a volatility of 11%, a risk-free interest rate of 2% per annum, and a share price of 75.00 DKK [4] - The estimated annual value of the warrants is 182,000 DKK until potential utilization [4] Company Overview - FirstFarms is a Danish stock exchange-listed company focused on sustainable operations and community responsibility [6]

The Unrecognized Faces of Critical Illness CytoSorbents Corporation Nasdaq: CTSO Q1 2024 Earnings Conference Call May 9, 2024 Conference Call Participants Moderator: Eric Ribner LifeSci Advisors Christian Steiner, MD Executive VP Sales & Marketing Managing Director CytoSorbents Europe GmbH Phillip Chan, MD, PhD Chief Executive Officer Vincent Capponi, MS President and Chief Operating Officer Kathleen Bloch, MBA, CPA Chief Financial Officer Efthymios "Makis" Deliargyris MD, FACC, FESC, FSCAI Chief Medical Of ...

The Unrecognized Faces of Critical Illness CytoSorbents Corporation Nasdaq: CTSO Q2 2024 Earnings Conference Call August 13, 2024 Conference Call Participants Moderator: Eric Ribner LifeSci Advisors Christian Steiner, MD Executive VP Sales & Marketing Managing Director CytoSorbents Europe GmbH Christopher Cramer, MS, MBA Senior VP Business Development 2 Phillip Chan, MD, PhD Chief Executive Officer Vincent Capponi, MS President and Chief Operating Officer Kathleen Bloch, MBA, CPA Chief Financial Officer Eft ...

The Emergence of CytoSorbents Corporation Nasdaq: CTSO Q3 2024 Earnings Conference Call November 7, 2024 DrugSorb-ATR is an investigational device currently under U.S. FDA and Health Canada review. It is not yet approved or cleared in any country. Conference Call Participants Moderator: Adanna Alexander, PhD ICR Healthcare Efthymios "Makis" Deliargyris MD, FACC, FESC, FSCAI Chief Medical Officer Christopher Cramer, MS, MBA Senior VP Business Development 2 Phillip Chan, MD, PhD Chief Executive Officer Vincen ...

东 兴 晨 报 2025 年 6 月 23 日星期一 经济要闻 1. 财政部：1—5 月证券交易印花税 668 亿元 同比增长 52.4%。财政部数 据显示，1—5 月，全国一般公共预算收入 96623 亿元，同比下降 0.3%。其中， 全国税收收入 79156 亿元，同比下降 1.6%；非税收入 17467 亿元，同比增长 6.2%。分中央和地方看，中央一般公共预算收入 41486 亿元，同比下降 3%； 地方一般公共预算本级收入 55137 亿元，同比增长 1.9%。1—5 月印花税 1787 亿元，同比增长 18.8%。其中，证券交易印花税 668 亿元，同比增长 52.4%。 （资料来源：同花顺） 2. 央行：跨境支付通支持内地与香港间人民币和港币的跨境汇款。央行有 关部门负责人就跨境支付通答记者问表示，跨境支付通是将中国内地快速支 付系统与其他货币当局的快速支付系统连接，制定配套政策安排，为中国内 地居民与境外居民间提供高效、便捷、安全的跨境支付服务。与传统跨境汇 款相比，跨境支付通有效缩短了跨境汇款链路，提高了跨境汇款效率，支持 用户通过参与机构的手机银行、网上银行等渠道，依托手机号码、银行账户 ...

当地时间6月22日，在经历多次延期之后， 特斯拉自动驾驶出租车Robotaxi在德克萨斯州奥斯汀正式启 动试点，向首批受邀用户开放体验 。据了解，特斯拉Robotaxi试点车队规模不大，初期仅配备约10辆车 辆，仅在地理围栏（Geo-fencing）区域内提供服务。 特斯拉CEO埃隆·马斯克也在社交平台上宣布"推出自动驾驶出租车"。他表示， 这是十年辛勤工作的成 果，特斯拉AI芯片和软件团队都是在特斯拉内部从零开始组建的。 Robotaxi上路运营，收取4.2美元固定费用 在社交平台上，马斯克表示："热烈祝贺特斯拉AI软件和芯片设计团队成功推出自动驾驶出租车！" 据了解，目前在奥斯汀特斯拉Robotaxi仅配备约10辆车辆，运营时间限制在上午6时至午夜12时之间， 且仅在地理围栏区域内提供服务。和之前宣传的无人驾驶不同，每辆车都在前排配备了安全员。 马斯克在社交媒体上表示，特斯拉自动驾驶出租车服务将固定收取4.20美元的统一费用。他强调，公司 在安全方面"格外谨慎"，特斯拉将配备专业团队实施远程监控干预，保障试运营的安全性。 马斯克表示，Robotaxi不仅是一项服务，更是"个人交通的终极形式"，能让出行更安 ...

从市场层面看，尽管近两年氢能市场发展未达预期，但业内人士依然对这一赛道的发展前景持有乐观态 度。 作为氢能产业链的核心环节之一，储氢技术在近些年来呈现出气态、液态和固态三种路线。目前，气态 储氢是现阶段最为成熟和应用最多的储氢技术。以车载储氢瓶为例，当前高压气态储氢主要采用铝内胆 纤维缠绕瓶（III型）、塑料内胆纤维缠绕瓶（IV型）作为容器。 "国内各地政府持续出台利好政策。另外，随着绿氢成本降低、加氢站等基础设施不断完善、电堆技术 升级等因素推动，氢燃料电池汽车市场规模将逐步扩大，车载储氢气瓶市场潜力依然巨大。"李桦圣分 析道。 在今年的国际氢能与燃料电池汽车大会暨展览会（FCVC 2025）上，21世纪经济报道记者注意到，储氢 瓶厂商均无一例外地展示了其IV型瓶产品。 需指出的是，机遇背后也存在挑战。例如，在车载储氢瓶领域，未来更多的企业将会参与竞争，国外企 业也会逐步布局。 "自2023年IV型瓶国标发布以来，市场量产进程就有所提速。"中材科技（苏州）有限公司副总经理李桦 圣在接受21世纪经济报道记者采访时指出，IV型瓶国标的发布，一方面明确了IV型瓶的材料选型、设 计制造、检测标准等关键信息，终结了此 ...